Carnero Contentti, Edgar https://orcid.org/0000-0001-7435-5726
López, Pablo A.
Pappolla, Agustín
Alonso, Ricardo
Silva, Berenice
Deri, Norma
Balbuena, María E.
Burgos, Marcos
Luetic, Geraldine
Alvez Pinheiro, Amelia
Cabrera, Mariela
Hryb, Javier
Nofal, Pedro
Pestchanker, Claudia
Vrech, Carlos
Tavolini, Darío
Tkachuk, Verónica
Zanga, Gisela
Marrodan, Mariano
Ysrraelit, María Célica
Correale, Jorge
Carrá, Adriana
Federico, Belén
Garcea, Orlando
Fernandez Liguori, Nora
Patrucco, Liliana
Cristiano, Edgardo
Giunta, Diego
Alonso Serena, Marina
Rojas, Juan I.
,
Funding for this research was provided by:
Novartis Pharma (COMB157GAR09R)
Article History
Received: 6 August 2023
Accepted: 19 December 2023
First Online: 30 December 2023
Declarations
:
: The registry was previously approved by all the participating centers in Argentina. All patients included in the study consent to be part of the registry and this specific research as well.
: the registry was previously approved by all the participating centers in Argentina. All patients included in the study consent to be part of the registry (wrtitten or oral) and this specific research as well, as mentioned in the body of the manuscript.
: Agustín Pappolla, Amelia Alvez Pinheiro, Mariela Cabrera, Javier Hryb, Pedro Nofal, Claudia Pestchanker, Mariano Marrodan, Gisela Zanga, Diego Giunta, and Marina Alonso Serena have nothing to disclose.Edgar Carnero Contentti has received reimbursement for developing educational presentations, educational and research grants, consultation fees, and travel stipends from Biogen Argentina and LATAM, Genzyme Argentina, Merck Argentina and LATAM, Roche Argentina and LATAM, Raffo, Novartis Argentina, AstraZeneca Argentina, Biosidus Argentina, LACTRIMS, Harvard Medical School (Postgraduate Medical Education), The Fumaira Fundation/Charite University of Berlin, and The Guthy-Jackson Charitable Foundation. Pablo Lopez has received reimbursement for developing educational presentations, educational and research grants, consultation fees, and travel stipends from Biogen, Genzyme, Novartis, Teva, Gador, Raffo, Biosidus, Synthon – Bagó, and Roche. Ricardo Alonso has received reimbursement for research grants and travel stipends from Merck, Biogen, and Genzyme. Berenice Silva has received fees for consultancy and Advisory Board membership and fees for travel, academic conferences, and research projects from Novartis, Merck Serono, Teva, Genzyme, and Biogen Idec. Norma Deri has received reimbursement for developing educational presentations, educational and research grants, consultation fees, and travel stipends from Biogen and Genzyme. María E. Balbuena has received consulting fees from Biogen, Novartis, and Genzyme as a lecturer from Merck Serono, Novartis, and Biogen, and collaboration for attendance to national and international congresses from Biogen, Novartis, Merck Serono, Bayer, and Gador. Marcos Burgos has received reimbursement for developing educational presentations, consultations fees, clinical trials fees, and travel stipends from Biogen, Genzyme, Merck, Novartis, Teva, and Tuteur. Geraldine Luetic has received reimbursement for research grants and travel stipends from Bagó, Raffo, and Biosidus. LP has received reimbursement for developing educational presentations, educational and research grants, consultations fees, and travel stipends from Biogen, Genzyme, Merck, and Novartis. Darío Tavolini has received reimbursement for developing educational presentations, educational and research grants, consultations fees, and travel stipends from Biogen, Genzyme, Merck, and Novartis. Verónica Tkachuk has received reimbursement for developing educational presentations, educational and research grants, consultations fees, and travel stipends from Schering Argentina, Bayer Schering Pharma, Bayer, Serono Argentina, and Merck. Carlos Vrech has received reimbursement for developing educational presentations, educational and research grants, consultations fees, and travel stipends from Bayer, Biogen, Genzyme, Merck, Novartis, Roche, Biosidus, Gador, and Raffo. Celica Ysrraelit has received reimbursement for developing educational presentations and travel/accommodations stipends from Merck-Serono Argentina, Biogen-Idec Argentina, Genzyme Argentina, Bayer Inc., Novartis Argentina, and TEVA-Tuteur Argentina. Jorge Correale has received reimbursement for developing educational presentations, educational and research grants, consultations fees, and travel stipends from Biogen, Genzyme, Merck, Novartis, and Roche. Adriana Carra has received reimbursement for developing educational presentations and travel/accommodations stipends from Merck-Serono Argentina, Biogen-Idec Argentina, Genzyme Argentina, Bayer Inc., Novartis Argentina, and TEVA-Tuteur Argentina. Orlando Garcea has received reimbursement for developing educational presentations and consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis, and Roche. Nora Fernandez Liguori has received reimbursement for developing educational presentations and travel/accommodations stipends from Merck-Serono Argentina, Biogen-Idec Argentina, Genzyme Argentina and Bayer Inc., and Novartis Argentina. Liliana Patrucco has received reimbursement for developing educational presentations, educational and research grants, consultations fees, and travel stipends from Biogen, Genzyme, Merck, Novartis, and Roche. Edgardo Cristiano has received reimbursement for developing educational presentations and travel/accommodations stipends from Merck-Serono Argentina, Biogen-Idec Argentina, Genzyme Argentina, Bayer Inc., Novartis Argentina, and TEVA-Tuteur Argentina. Juan I. Rojas has received reimbursement for developing educational presentations, educational and research grants, consultations fees, and travel stipends from Biogen, Genzyme, Merck, Novartis, Roche, and MSIF.